316 related articles for article (PubMed ID: 11373582)
21. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
Kennedy MT; Jordan RC; Berean KW; Perez-OrdoƱez B
J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
[TBL] [Abstract][Full Text] [Related]
22. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis.
Tot T; Samii S
APMIS; 2003 Dec; 111(12):1075-82. PubMed ID: 14678015
[TBL] [Abstract][Full Text] [Related]
23. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
Dai L; Song Q; Li L; Zhong D; Hui Y
Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):114-7. PubMed ID: 11866966
[TBL] [Abstract][Full Text] [Related]
24. Lung adenocarcinomas metastatic to the brain with and without ultrastructural evidence of rootlets: an electron microscopic and immunohistochemical study using cytokeratins 7 and 20 and villin.
Sharma S; Tan J; Sidhu G; Wieczorek R; Miller DC; Cassai ND
Ultrastruct Pathol; 1998; 22(5):385-91. PubMed ID: 9887481
[TBL] [Abstract][Full Text] [Related]
25. Utility of CK7 and CK20 immunohistochemistry in the detection of synchronous breast and colon carcinoma in a pleural effusion: a case report and supporting survey of archival material.
Stopyra GA; Warhol MJ; Multhaupt HA
Diagn Cytopathol; 2001 Jul; 25(1):54-8. PubMed ID: 11466814
[TBL] [Abstract][Full Text] [Related]
26. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets.
Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R
Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790
[TBL] [Abstract][Full Text] [Related]
27. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas.
Zhang PJ; Shah M; Spiegel GW; Brooks JJ
Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):306-10. PubMed ID: 14663355
[TBL] [Abstract][Full Text] [Related]
28. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
Mohammed IA; Streutker CJ; Riddell RH
Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
[TBL] [Abstract][Full Text] [Related]
29. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.
Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R
Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647
[TBL] [Abstract][Full Text] [Related]
30. Cytokeratin 7 and 20 expression in gallbladder carcinoma.
Kalekou H; Miliaras D
Pol J Pathol; 2011; 62(1):25-30. PubMed ID: 21574103
[TBL] [Abstract][Full Text] [Related]
31. Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases.
Tot T
Ann Diagn Pathol; 1999 Dec; 3(6):350-6. PubMed ID: 10594286
[TBL] [Abstract][Full Text] [Related]
32. Adenocarcinomas of the nasal cavity and paranasal sinuses: a clinicopathological and immunohistochemical study of 14 cases.
Abecasis J; Viana G; Pissarra C; Pereira T; Fonseca I; Soares J
Histopathology; 2004 Sep; 45(3):254-9. PubMed ID: 15330803
[TBL] [Abstract][Full Text] [Related]
33. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma.
Tot T
Eur J Cancer; 2002 Apr; 38(6):758-63. PubMed ID: 11937308
[TBL] [Abstract][Full Text] [Related]
34. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Ciampa A; Fanger G; Khan A; Rock KL; Xu B
Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
36. Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression.
Nowak MA; Guerriere-Kovach P; Pathan A; Campbell TE; Deppisch LM
Arch Pathol Lab Med; 1998 Dec; 122(12):1077-81. PubMed ID: 9870855
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: their histological diversity and the expression of markers useful for differentiation from metastatic cancer.
Ikota H; Tanaka Y; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2011 Jul; 28(3):215-21. PubMed ID: 21394517
[TBL] [Abstract][Full Text] [Related]
38. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
Gyure KA; Morrison AL
Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor.
Han AC; Duszak R
Cancer; 1999 Dec; 86(11):2327-30. PubMed ID: 10590374
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]